Status:
RECRUITING
BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases
Lead Sponsor:
Umeå University
Collaborating Sponsors:
Uppsala University
Karolinska Institutet
Conditions:
Breast Cancer
Liver Metastases
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Breast cancer is the second most common cancer in Sweden with an incidence of 8000 per year. The role of surgery for distant breast cancer metastasis beyond local lymph nodes remains controversial eve...
Eligibility Criteria
Inclusion
- Signed informed consent
- \>18 years old
- ECOG 0-1
- Breast cancer history
- Breast cancer liver metastasis verified by biopsy
- Patient amendable for liver surgery and pre- and postoperative oncological treatment
- 1-4 liver metastasis amendable to surgery with functional liver remnant volume \>30%
- Liver metastasis (and skeletal metastasis) stable or responding to preoperative oncological treatment
Exclusion
- Non-skeletal extrahepatic disease
- Non-resected primary tumour
- Pregnancy
- Progression of disease upon oncological treatment
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04079049
Start Date
January 1 2020
End Date
December 31 2029
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Umeå University Hospital
Umeå, Sweden, 90185